Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun City, Jilin Province, China.
Int Rev Immunol. 2021;40(3):183-196. doi: 10.1080/08830185.2020.1800687. Epub 2020 Aug 12.
More and more exosome-based therapeutics are being developed with advances in nanotechnology and precision medicine. Exosome is a kind of tiny vesicles with a bilayer of phospholipids, which can transfer biological macromolecules to recipients to influence the biological process. M2 macrophages are closely related to the occurrence and development of serious diseases such as tumor. In addition to the traditional concept of macrophage functions such as opsonization, secretion of cytokines and other soluble factors, some studies have found that the exosome derived from M2 macrophages can influence the development of disease by carrying microRNA, long noncodingRNA and functional proteins to regulate target gene expression as well as related proteins synthesis recently. Here, we outlined the biogenesis of the exosome and its biological functions in disease. Then we focused on elucidating the effects of the exosome derived from M2 macrophages on several diseases and its mechanisms. Finally, we discussed the appropriateness and inappropriateness in existing potential applications based on exosomes and macrophages.
随着纳米技术和精准医学的进步,越来越多的基于外泌体的疗法正在被开发。外泌体是一种带有双层磷脂的微小囊泡,它可以将生物大分子传递给受体,从而影响生物过程。M2 巨噬细胞与肿瘤等严重疾病的发生和发展密切相关。除了传统的巨噬细胞功能概念,如调理作用、细胞因子和其他可溶性因子的分泌外,最近的一些研究发现,M2 巨噬细胞衍生的外泌体可以通过携带 microRNA、长非编码 RNA 和功能蛋白来调节靶基因表达以及相关蛋白合成,从而影响疾病的发展。在这里,我们概述了外泌体的生物发生及其在疾病中的生物学功能。然后,我们重点阐述了 M2 巨噬细胞衍生的外泌体对几种疾病的影响及其机制。最后,我们根据外泌体和巨噬细胞讨论了现有潜在应用的适宜性和不适宜性。